Sign in
Taking people in PortugalNo phase

Myval heart valve replacement in people with severe aortic valve stenosis

Follows safety and performance of the Myval valve in adults with severe aortic stenosis.

Key facts

Who runs it
Portuguese Association of Interventional Cardiology
Where
Carnaxide, Coimbra, Evora, Lisbon, and Porto, PortugalSee the 6 sites
Trial code
Registry title
Portuguese Registry With Meril Myval THV Series - MyPORTuVal Registry
Status
Recruiting
People taking part
150 people, planned
Started
13 May 2025
Expected to end
Nov 2028
Type of study
Observational
Treatments tested
  • Myval THV series
Record updated
16 January 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with severe aortic valve narrowing that causes symptoms. Their heart team plans to replace the valve through a catheter (TAVI) using the Myval THV series.

Age
Over 18 years
Sex
All sexes
Disease stage
Symptomatic severe narrowing of the person's own aortic valve (aortic stenosis).

Main reasons for not taking part

  • Allergy to aspirin, heparin, clopidogrel, ticlopidine, cobalt, nickel, chromium, molybdenum or any contrast dye
  • Ongoing infection of the heart lining (infective endocarditis) or a similar infection
  • Pregnant or breastfeeding
  • Liver failure (Child-Pugh Class B or C)
  • Taking part in another clinical study that has not reached its main goal

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Patient over the age of 18 years with symptomatic aortic stenosis (severe AS), intended to perform TAVI procedure using Myval THV series as assessed by Heart Team
  • Patient has provided written informed consent as approved by the Ethics Committee (EC)
  • Patient is willing to undergo all registry procedures and follow-up requirements

Who cannot take part

  • Patients with hyper sensitivity or allergy to aspirin, heparin, clopidogrel, ticlopidine, cobalt, nickel, chromium, molybdenum or any contrast media
  • Ongoing infective endocarditis or any similar infection
  • Liver failure (Child-Pugh Class B or C)
  • Any condition, which in the investigator opinion, would preclude safe participation of the patient in the Registry
  • Pregnant or lactating females
  • Patient is currently participating in another clinical investigation where the primary endpoint has not been achieved

Where in Portugal

  • Unidade Local de Saúde do Lisboa Ocidental E.P.E. - Hospital Santa CruzCarnaxide, PortugalContact: Sílvio Leal, MDTaking people
  • Unidade Local de Saude de CoimbraCoimbra, PortugalContact: Joana D Silva, Prof. Dr.Taking people
  • Unidade Local de Saúde Alentejo Central E.P.E. - Hospital Espírito SantoEvora, PortugalContact: Lino Patrício, Prof. Dr.Taking people
  • Unidade Local de Saúde de Santa Maria, E. P. E. - Hospital de Santa MariaLisbon, PortugalContact: Pedro C Ferreira, MDTaking people
  • Unidade Local de Saúde de São José E.P.E. - Hospital Santa MartaLisbon, PortugalContact: Duarte Cacela, MDNot yet recruiting
  • Unidade Local de São João E.P.E.Porto, PortugalContact: Domingos MagalhãesNot yet recruiting

About the trial

What the trial wants to find out

A prospective, single-arm, multi-centre registry to evaluate the safety and performance of Myval THV series using Transcatheter Aortic Valve Implantation (TAVI) procedure in patients with symptomatic severe native aortic valve stenosis.

Treatments tested

  • Myval THV series

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Portuguese Registry With Meril Myval THV Series - MyPORTuVal Registry
Plain-language title
Myval heart valve replacement in people with severe aortic valve stenosisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
16 January 2026